Results 191 to 200 of about 16,152 (253)

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli   +17 more
wiley   +1 more source

Metastatic Papillary Thyroid Carcinoma Without Intrathyroidal Primary: Case Report and Literature Review. [PDF]

open access: yesCase Rep Surg
Alsayyari MS   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy